A detailed history of Ironwood Investment Counsel, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Ironwood Investment Counsel, LLC holds 3,204 shares of NVO stock, worth $352,856. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,204
Previous 3,204 -0.0%
Holding current value
$352,856
Previous $411,000 11.19%
% of portfolio
0.09%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$87.78 - $105.45 $22,296 - $26,784
-254 Reduced 7.35%
3,204 $331,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $173,149 - $379,924
1,904 Added 122.52%
3,458 $314,000
Q2 2023

Aug 08, 2023

SELL
$155.98 - $172.65 $22,773 - $25,206
-146 Reduced 8.59%
1,554 $251,000
Q4 2022

Feb 01, 2023

BUY
$102.55 - $135.33 $174,335 - $230,061
1,700 New
1,700 $230,000
Q1 2022

May 09, 2022

BUY
$93.1 - $112.54 $195,510 - $236,334
2,100 New
2,100 $233,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $249B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Ironwood Investment Counsel, LLC Portfolio

Follow Ironwood Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironwood Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironwood Investment Counsel, LLC with notifications on news.